Prodrugs of Non-steroidal Anti-inflammatory Drugs (NSAIDs): A Long March Towards Synthesis of Safer NSAIDs

Abstract

As a therapeutic group, non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used, prescribed and over the counter (OTC) medications for the treatment of inflammatory diseases, but suffering from several undesired side effects, the most important being ulcerogenicity, mucosal hemorrhage and gastritis. Most of the NSAID moieties are chemically composed of carboxylic functional groups and this could be one of the reasons for the damage to the mucosal lining. The prodrug designing is one of the several strategies used to overcome this drawback. Hence, in the last decade, the design and the synthesis of prodrugs of NSAIDs have been explored and given much attention by medicinal chemists. The rationale behind the prodrug concept is to achieve temporary blockade of the free carboxylic group present in the NSAIDs till their systemic absorption. This review is aimed to highlight and provide important information on NSAID prodrugs that have been designed and reported to be safe and more effective. This review will also focus on NSAID prodrugs that have been designed for improving therapeutic i.e. anti-inflammatory action as well as improving drug delivery at the target site. The most common derivatives of carboxylic NSAIDs that are discussed here belong to the chemical classes of esters, amides, anhydrides, acetals and the other derivatives with completely masked carboxylic groups. The successful prodrugs were listed and their molecular structures were also demonstrated here. The present review covers the recent updates present in literature and will surely provide a greater insight into the designing of safer NSAIDs in the future.

Low dose of flurbiprofen axetil decrease the rate of acute kidney injury after operation: a retrospective clinical data analysis of 9915 cases

“…The use of nephrotoxic drugs was an important contributor for postoperative AKI, which has been demonstrated previously [6]. NSAIDs are the cornerstone of pain management in patients who have acute pain (eg, postoperative pain) for their analgesic and anti-inflammatory effects [16]. As a kind of targeted NSAIDs, intravenous administration of FA has been often used to reduce perioperative pain.…”

Anti‐Inflammatory Effect of Novel 7‐Substituted Coumarin Derivatives through Inhibition of NF‐κB Signaling Pathway

“…[6] The latter inhibit COX-1 and COX-2 simultaneously; however, they may cause adverse gastric effects that lead to patient intolerance. [7] Therefore, to aim at the mechanisms of inflammation, exploring and developing new anti-inflammatory drugs are important.…”

Novel ketoprofen–antioxidants mutual codrugs as safer nonsteroidal anti‐inflammatory drugs: Synthesis, kinetic and pharmacological evaluation

“…Various studies revealed that GI intolerance and poor patient compliance are the major limitations of NSAIDS therapy and, therefore, to design and develop gastric‐sparing and gastro‐protecting NSAIDS is a hot area of drug research. Since the last two decades, NSAIDs have been altered in varied ways with the aim of designing safe, more effective NSAIDs with reduced GI toxicity . These approaches include: …”